Utah Medical Products Total Liabilities and Share Holders Equity 2010-2024 | UTMD

Utah Medical Products total liabilities and share holders equity from 2010 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
Utah Medical Products Annual Total Liabilities and Share Holders Equity
(Millions of US $)
2024 $123
2023 $135
2022 $124
2021 $116
2020 $112
2019 $110
2018 $100
2017 $93
2016 $76
2015 $79
2014 $81
2013 $81
2012 $77
2011 $76
2010 $41
2009 $42
Utah Medical Products Quarterly Total Liabilities and Share Holders Equity
(Millions of US $)
2024-12-31 $123
2024-09-30 $130
2024-06-30 $130
2024-03-31 $135
2023-12-31 $135
2023-09-30 $131
2023-06-30 $130
2023-03-31 $128
2022-12-31 $124
2022-09-30 $118
2022-06-30 $116
2022-03-31 $120
2021-12-31 $116
2021-09-30 $120
2021-06-30 $117
2021-03-31 $114
2020-12-31 $112
2020-09-30 $107
2020-06-30 $104
2020-03-31 $103
2019-12-31 $110
2019-09-30 $104
2019-06-30 $103
2019-03-31 $105
2018-12-31 $100
2018-09-30 $99
2018-06-30 $97
2018-03-31 $97
2017-12-31 $93
2017-09-30 $91
2017-06-30 $86
2017-03-31 $82
2016-12-31 $76
2016-09-30 $83
2016-06-30 $81
2016-03-31 $83
2015-12-31 $79
2015-09-30 $80
2015-06-30 $80
2015-03-31 $75
2014-12-31 $81
2014-09-30 $82
2014-06-30 $84
2014-03-31 $83
2013-12-31 $81
2013-09-30 $81
2013-06-30 $76
2013-03-31 $76
2012-12-31 $77
2012-09-30 $79
2012-06-30 $77
2012-03-31 $80
2011-12-31 $76
2011-09-30 $79
2011-06-30 $81
2011-03-31 $82
2010-12-31 $41
2010-09-30 $44
2010-06-30 $43
2010-03-31 $44
2009-12-31 $42
2009-09-30 $42
2009-06-30 $40
2009-03-31 $41
Sector Industry Market Cap Revenue
Medical MED PRODUCTS $0.173B $0.041B
Utah Medical Products is in the business of producing cost-effective devices for the healthcare industry which are predominantly proprietary, disposable and for hospital use. The company's success in rapidly producing solutions comes from its proven ability to integrate a number of engineering and technical disciplines in electronics, software, mechanical packaging, instrumentation, optics and materials. The resulting proprietary products represent significant incremental improvementsover existing clinical techniques.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) US $231.085B 27.79
Boston Scientific (BSX) US $155.238B 38.86
Stryker (SYK) US $144.362B 30.18
EssilorLuxottica (ESLOY) FR $132.860B 0.00
Medtronic (MDT) IE $108.824B 15.89
Lonza Group Ag (LZAGY) CH $52.624B 0.00
Haleon (HLN) GB $48.259B 27.44
ResMed (RMD) US $35.183B 26.43
GE HealthCare Technologies (GEHC) US $32.295B 15.33
Agilent Technologies (A) US $30.971B 20.46
Terumo (TRUMY) JP $29.019B 0.00
Koninklijke Philips (PHG) NL $24.053B 17.17
Zimmer Biomet Holdings (ZBH) US $20.255B 12.80
Insulet (PODD) US $18.084B 77.18
Baxter (BAX) US $15.752B 11.77
Smith & Nephew SNATS (SNN) GB $12.535B 0.00
Sunny Optical Technology (SNPTF) CN $9.032B 0.00
Demant (WILYY) DK $7.970B 0.00
Lantheus Holdings (LNTH) US $7.447B 18.31
Bio-Rad Laboratories (BIO) US $6.620B 22.38
Prestige Consumer Healthcare (PBH) US $4.171B 19.90
Perrigo (PRGO) IE $3.497B 10.01
ICU Medical (ICUI) US $3.486B 29.69
Shandong Weigao Medical Polymer (SHWGF) CN $3.459B 0.00
Haemonetics (HAE) US $3.208B 15.10
Envista Holdings (NVST) US $2.880B 23.93
GN Store Nord (GNNDY) DK $2.068B 17.13
QuidelOrtho (QDEL) US $1.964B 16.45
LeMaitre Vascular (LMAT) US $1.778B 39.75
AtriCure (ATRC) US $1.486B 0.00
Green Thumb Industries (GTBIF) US $1.374B 21.63
Neogen (NEOG) US $1.248B 15.97
Kestra Medical Technologies (KMTS) US $1.220B 0.00
BioLife Solutions (BLFS) US $1.200B 0.00
AdaptHealth (AHCO) US $1.184B 11.40
InMode (INMD) IL $1.013B 9.28
Phibro Animal Health (PAHC) US $0.789B 12.10
Evolus (EOLS) US $0.779B 0.00
Curaleaf Holdings (CURLF) CA $0.637B 0.00
CeriBell (CBLL) US $0.588B 0.00
Owens & Minor (OMI) US $0.580B 4.94
Valneva SE (VALN) FR $0.549B 0.00
Capricor Therapeutics (CAPR) US $0.542B 0.00
Maravai LifeSciences Holdings (MRVI) US $0.526B 0.00
Tilray Brands (TLRY) CA $0.458B 0.00
Cresco Labs (CRLBF) US $0.442B 0.00
Omeros (OMER) US $0.418B 0.00
Surmodics (SRDX) US $0.395B 0.00
SNDL (SNDL) CA $0.365B 0.00
VAREX IMAGING (VREX) US $0.359B 15.55
SEMPERIT AG HLD (SEIGY) AT $0.317B 0.00
Verano Holdings (VRNOF) US $0.296B 0.00
Sanara MedTech (SMTI) US $0.292B 0.00
Viemed Healthcare (VMD) US $0.291B 26.32
Aurora Cannabis (ACB) CA $0.272B 48.40
Sanuwave Health (SNWV) US $0.264B 0.00
ZimVie (ZIMV) US $0.261B 15.60
Cerus (CERS) US $0.258B 0.00
Canopy Growth (CGC) CA $0.245B 0.00
Quanterix (QTRX) US $0.233B 0.00
OraSure Technologies (OSUR) US $0.231B 0.00
High Tide (HITI) CA $0.194B 0.00
Biote (BTMD) US $0.190B 4.35
Brainsway (BWAY) IL $0.170B 53.06
TriSalus Life Sciences (TLSI) US $0.165B 0.00
Organigram Global (OGI) CA $0.154B 0.00
FitLife Brands (FTLF) US $0.148B 18.22
Jin Medical (ZJYL) CN $0.119B 0.00
TerrAscend (TSNDF) CA $0.116B 0.00
MacroGenics (MGNX) US $0.110B 0.00
Exagen (XGN) US $0.108B 0.00
Agape ATP (ATPC) $0.099B 0.00
Oramed Pharmaceuticals (ORMP) US $0.095B 0.00
Quipt Home Medical (QIPT) US $0.094B 0.00
Fonar (FONR) US $0.076B 10.70
Jushi Holdings (JUSHF) US $0.076B 0.00
Veru (VERU) US $0.075B 0.00
InterCure (INCR) IL $0.073B 0.00
Zynex (ZYXI) US $0.070B 0.00
United Health Products (UEEC) US $0.064B 0.00
Cytosorbents (CTSO) US $0.059B 0.00
ImmuCell (ICCC) US $0.048B 0.00
Apyx Medical (APYX) US $0.047B 0.00
Modular Medical (MODD) US $0.042B 0.00
Rockwell Medical (RMTI) US $0.042B 61.50
United-Guardian (UG) US $0.037B 11.28
Safety Shot (SHOT) US $0.036B 0.00
Nephros (NEPH) US $0.020B 0.00
INLIF (INLF) $0.018B 0.00
Trinity Biotech (TRIB) IE $0.015B 0.00
Cellectar Biosciences (CLRB) US $0.012B 0.00
Flora Growth (FLGC) US $0.012B 0.00
Allurion Technologies (ALUR) US $0.011B 0.00
NeuroMetrix (NURO) US $0.009B 0.00
Meihua Medical Technologies (MHUA) CN $0.007B 0.00
Innovative Eyewear (LUCY) US $0.005B 0.00
GlucoTrack (GCTK) US $0.004B 0.00
Senestech (SNES) US $0.004B 0.00
IM Cannabis (IMCC) CA $0.004B 0.00
Akanda (AKAN) GB $0.002B 0.00
Sharps Technology (STSS) US $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) US $0.000B 0.00